| Autor: |
Perrotta C; Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences 'Luigi Sacco' (DIBIC), National Research Council-Institute of Neuroscience, University Hospital 'Luigi Sacco', Università di Milano, 20157, Milan, Italy., Cervia D, De Palma C, Assi E, Pellegrino P, Bassi MT, Clementi E |
| Jazyk: |
angličtina |
| Zdroj: |
Apoptosis : an international journal on programmed cell death [Apoptosis] 2015 May; Vol. 20 (5), pp. 635-44. |
| DOI: |
10.1007/s10495-015-1101-9 |
| Abstrakt: |
Autophagy, the main intracellular process of cytoplasmic material degradation, is involved in cell survival and death. Autophagy is regulated at various levels and novel modulators of its function are being continuously identified. An intriguing recent observation is that among these modulators is the sphingolipid metabolising enzyme, Acid Sphingomyelinase (A-SMase), already known to play a fundamental role in apoptotic cell death participating in several pathophysiological conditions. In this review we analyse and discuss the relationship between autophagy and A-SMase describing how A-SMase may regulate it and defining, for the first time, the existence of an A-SMase-autophagy axis. The imbalance of this axis plays a role in cancer, nervous system, cardiovascular, and hepatic disorders. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink